These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1400330)

  • 61. The interaction of fibulin-1 with fibrinogen. A potential role in hemostasis and thrombosis.
    Tran H; Tanaka A; Litvinovich SV; Medved LV; Haudenschild CC; Argraves WS
    J Biol Chem; 1995 Aug; 270(33):19458-64. PubMed ID: 7642629
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of the fibrin-binding activities in the N- and C-termini of fibronectin.
    Rostagno AA; Schwarzbauer JE; Gold LI
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):375-86. PubMed ID: 10024513
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interaction of heparin with a synthetic pentadecapeptide from the C-terminal heparin-binding domain of fibronectin.
    Hari SP; McAllister H; Chuang WL; Christ MD; Rabenstein DL
    Biochemistry; 2000 Apr; 39(13):3763-73. PubMed ID: 10736176
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly.
    Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A
    Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structural characterization of two variants of fibulin-1 that differ in nidogen affinity.
    Sasaki T; Kostka G; Göhring W; Wiedemann H; Mann K; Chu ML; Timpl R
    J Mol Biol; 1995 Jan; 245(3):241-50. PubMed ID: 7844816
    [TBL] [Abstract][Full Text] [Related]  

  • 66. RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities.
    McCarthy JB; Skubitz AP; Qi Z; Yi XY; Mickelson DJ; Klein DJ; Furcht LT
    J Cell Biol; 1990 Mar; 110(3):777-87. PubMed ID: 2307707
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Human fibulin-1D: molecular cloning, expression and similarity with S1-5 protein, a new member of the fibulin gene family.
    Tran H; Mattei M; Godyna S; Argraves WS
    Matrix Biol; 1997 Mar; 15(7):479-93. PubMed ID: 9106159
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Endothelial cell interactions with synthetic peptides from the carboxyl-terminal heparin-binding domains of fibronectin.
    Huebsch JC; McCarthy JB; Diglio CA; Mooradian DL
    Circ Res; 1995 Jul; 77(1):43-53. PubMed ID: 7788881
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fibronectin's cell-adhesive domain and an amino-terminal matrix assembly domain participate in its assembly into fibroblast pericellular matrix.
    McDonald JA; Quade BJ; Broekelmann TJ; LaChance R; Forsman K; Hasegawa E; Akiyama S
    J Biol Chem; 1987 Mar; 262(7):2957-67. PubMed ID: 3818629
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fibronectin and heparin binding domains of latent TGF-beta binding protein (LTBP)-4 mediate matrix targeting and cell adhesion.
    Kantola AK; Keski-Oja J; Koli K
    Exp Cell Res; 2008 Aug; 314(13):2488-500. PubMed ID: 18585707
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A fibronectin self-assembly site involved in fibronectin matrix assembly: reconstruction in a synthetic peptide.
    Morla A; Ruoslahti E
    J Cell Biol; 1992 Jul; 118(2):421-9. PubMed ID: 1629240
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa.
    Wayner EA; Carter WG; Piotrowicz RS; Kunicki TJ
    J Cell Biol; 1988 Nov; 107(5):1881-91. PubMed ID: 2846588
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Localization of the major heparin-binding site in fibronectin.
    Barkalow FJ; Schwarzbauer JE
    J Biol Chem; 1991 Apr; 266(12):7812-8. PubMed ID: 2019604
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.
    Jalkanen S; Jalkanen M
    J Cell Biol; 1992 Feb; 116(3):817-25. PubMed ID: 1730778
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tenascin-C binds heparin by its fibronectin type III domain five.
    Weber P; Zimmermann DR; Winterhalter KH; Vaughan L
    J Biol Chem; 1995 Mar; 270(9):4619-23. PubMed ID: 7533163
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of binding of fibronectin to matrix assembly sites by anti-integrin (alpha 5 beta 1) antibodies.
    Fogerty FJ; Akiyama SK; Yamada KM; Mosher DF
    J Cell Biol; 1990 Aug; 111(2):699-708. PubMed ID: 2380248
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Collagen-binding domain of human plasma fibronectin contains a latent type-IV collagenase.
    Lambert Vidmar S; Lottspeich F; Emod I; Imhoff JM; Keil-Dlouha V
    Eur J Biochem; 1991 Oct; 201(1):79-84. PubMed ID: 1655429
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits.
    Wayner EA; Carter WG
    J Cell Biol; 1987 Oct; 105(4):1873-84. PubMed ID: 2822727
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evidence that binding to the carboxyl-terminal heparin-binding domain (Hep II) dominates the interaction between plasma fibronectin and heparin.
    Benecky MJ; Kolvenbach CG; Amrani DL; Mosesson MW
    Biochemistry; 1988 Sep; 27(19):7565-71. PubMed ID: 3207688
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts.
    Tremble P; Chiquet-Ehrismann R; Werb Z
    Mol Biol Cell; 1994 Apr; 5(4):439-53. PubMed ID: 7519905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.